Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04647916 |
|
Recruitment Status :
Recruiting
First Posted : December 1, 2020
Last Update Posted : August 14, 2023
|
Sponsor:
SWOG Cancer Research Network
Collaborators:
National Cancer Institute (NCI)
Gilead Sciences
Information provided by (Responsible Party):
SWOG Cancer Research Network
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | February 17, 2025 |
| Estimated Study Completion Date : | December 2026 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):